E-LIB Suche - Ergebnisse für: Yeku, O.O.

1

102P Interim safety analysis of a phase II trial of cisplat..:

Yeku, O.O. ; Russo, A. ; Bregar, A....
Immuno-Oncology and Technology. 20 (2023) - p. 100574 , 2023

Link: https://doi.org/10.1016/..

2

126P Evaluation of myeloid targeting agents, PY159 and PY31..:

Yeku, O.O. ; Barve, M. ; Tan, W.W....
Immuno-Oncology and Technology. 20 (2023) - p. 100598 , 2023

Link: https://doi.org/10.1016/..

3

127P REGN5668 (MUC16xCD28 bispecific antibody) with cemipli..:

Winer, I.S. ; O'Cearbhaill, R.E. ; Bouberhan, S....
Immuno-Oncology and Technology. 20 (2023) - p. 100599 , 2023

Link: https://doi.org/10.1016/..

4

41P Phase I analysis of ubamatamab (MUC16xCD3 bispecific an..:

Moore, K.N. ; O'Malley, D. ; Van Nieuwenhuysen, E....
ESMO Open. 8 (2023) 1 - p. 100821 , 2023

Link: https://doi.org/10.1016/..

5

159P COM701 in combination with nivolumab demonstrates prel..:

Yeku, O. ; D. Shepard ; Patel, M....
Immuno-Oncology and Technology. 16 (2022) - p. 100271 , 2022

Link: https://doi.org/10.1016/..

6

158P Triple blockade of the DNAM-axis with COM701 + BMS-986..:

Moroney, J. ; Yeku, O. ; Fleming, G....
Immuno-Oncology and Technology. 16 (2022) - p. 100270 , 2022

Link: https://doi.org/10.1016/..

7

Effect of Mismatch Repair Status on Outcome of Early Stage ..:

Russo, A.L. ; Wo, J.Y. ; Niemierko, A....
International Journal of Radiation Oncology*Biology*Physics. 108 (2020) 3 - p. e457-e458 , 2020

Link: https://doi.org/10.1016/..

8

A prospective, large-scale patient-reported outcomes progra..:

Sisodia, R. Clark ; Saini, A. ; Growdon, W.B....
Gynecologic Oncology. 159 (2020) - p. 76 , 2020

Link: https://doi.org/10.1016/..

9

Bispecific engager immunotherapy targeting the retained por..:

Yeku, O. ; Rao, T.D. ; Purdon, T...
Gynecologic Oncology. 154 (2019) - p. 57 , 2019

Link: https://doi.org/10.1016/..

10

A phase II trial of TPIV200 (a polypeptide vaccine against ..:

Yeku, O. ; Zamarin, D. ; Gallagher, J...
Gynecologic Oncology. 149 (2018) - p. 56-57 , 2018

Link: https://doi.org/10.1016/..

11

Phase I/II Study of Combined BCL-xL and MEK Inhibition with..:

Corcoran, Ryan B. ; Do, Khanh T. ; Kim, Jeong E....
Clinical Cancer Research. 30 (2024) 9 - p. 1739-1749 , 2024

Link: https://doi.org/10.1158/..

12

High-Grade Endometrial Cancer: Molecular Subtypes, Current ..:

Matoba, Yusuke ; Devins, Kyle M. ; Milane, Lara...
Reproductive Sciences. , 2024

Link: https://doi.org/10.1007/..

13

Targeting Galectin 3 illuminates its contributions to the p..:

Matoba, Yusuke ; Zarrella, Dominique T. ; Pooladanda, Venkatesh...
British Journal of Cancer. 130 (2024) 9 - p. 1463-1476 , 2024

Link: https://doi.org/10.1038/..

14

Structural basis for antibody recognition of the proximal M..:

Lee, Kwangkook ; Perry, Kay ; Xu, Mengyao...
Journal of Ovarian Research. 17 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

15

Racial disparities and referral for genetic counseling:

Yeku, Oladapo O.
Cancer. 130 (2023) 4 - p. 505-506 , 2023

Link: https://doi.org/10.1002/..